Fairvalue-Calculator Fairvalue-Calculator
EN DE

Everybot Inc (270660) Fair Value & Analysis

Technology · KR · Market cap 152B KRW

Price11,650 KRW
Fair Value9,106 KRW
Upside-21.8%
Quality94/100
Evidence: Low Range 6,830 KRW – 11,383 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Everybot Inc (270660) currently trades at 11,650 KRW, while our model-based Fair Value estimate is 9,106 KRW — implying the stock looks roughly 21.8% overvalued today. We read business quality at 94/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Everybot Inc. operates as a home service robot company worldwide. It offers wet mop robot cleaners and robotic vacuums, as well as related accessories. The company was founded in 2015 and is headquartered in Gwacheon-si, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Everybot Inc (270660) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 9,106 KRW versus a price of 11,650 KRW — about −22% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 270660?
Our 21-model fair value for Everybot Inc is 9,106 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 11,650 KRW.
What is the quality score of 270660?
Everybot Inc has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.